The Impact of COVID-19 Vaccines on the Development of Acute Complications in Type 1 and 2 Diabetes Patients: A Cross-Sectional Study in the Eastern Province of Saudi Arabia

Background: COVID-19 vaccines were developed to control the pandemic spread as they have been proven to be efficient and safe. However, the likelihood of such postvaccination effects as poor glycemic control and adverse events has been noted in several studies. Objective: To determine the effect of...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of general medicine Vol. 16; pp. 4267 - 4277
Main Authors Alhawaj, Sharook A, Almuhanna, Alia Saeed, Saeed Alabbad, Fatimah, Hisham Almomattin, Hadeel, Alsultan, Ragad S, Shaiban, Zahra Abdulla, Vatte, Chittibabu, Cyrus, Cyril
Format Journal Article
LanguageEnglish
Published Dove Medical Press Limited 30.09.2023
Dove
Dove Medical Press
Subjects
covid-19
Development and progression
diabetes
diabetes complications
Diabetics
hyperglycemic emergencies
Medical research
Medicine, Experimental
Original Research
Pharmaceutical industry
Type 2 diabetes
Vaccination
vaccine
Vaccines
Saudi Arabia
United States
United Kingdom
Online AccessGet full text

Cover

More Information
Summary:Background: COVID-19 vaccines were developed to control the pandemic spread as they have been proven to be efficient and safe. However, the likelihood of such postvaccination effects as poor glycemic control and adverse events has been noted in several studies. Objective: To determine the effect of COVID-19 vaccines on the glycemic control and the development of hyperglycemic emergencies among type 1 and 2 diabetes patients. Methods: A cross-sectional study was conducted on 409 participants aged 18 years and above with type 1 or 2 diabetes who had received at least a single dose of COVID-19 vaccine. Results: Among the 409 diabetes patients, a majority reported general mild postvaccination symptoms regardless of diabetes duration or type. After vaccination, severe diabetic emergencies were mostly reported in long-standing diabetes patients. Diabetes-related complications and emergencies were more profound among those who had received the Pfizer vaccine. Nonetheless, occurrence of adverse events could possibly be due to various factors, including the duration of diabetes and COVID-19 infection status. Conclusion: COVID-19 vaccinations have the potential to influence diabetic patients in regard to acute glycemic complications. However, vaccine efficiency and benefits are superior to the side effects of COVID-19 vaccines, as these adverse events only affect a small number of individuals. A need for postvaccination monitoring of diabetes patients is suggested. Keywords: diabetes, vaccine, COVID-19, hyperglycemic emergencies, diabetes complications
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1178-7074
1178-7074
DOI:10.2147/IJGM.S431179